When Roger Scarlett-Smith was first posted to Pittsburgh in the mid-1990s, his UK colleagues were quick to offer their condolences.
“When I came out here, people in London felt it was like a [prison] sentence,” says the British-born president at GlaxoSmithKline, the pharmaceutical giant.
